A study by Halef Okan Doğan and colleagues revealed dysregulated leukotriene metabolism in COVID-19 patients, with CYSLTR1 expression higher in the ICU group compared to the non-ICU group (Doğan et al., 2024). This evidence concerns the gene CYSLTR1 and COVID-19.